Carolin Kurz
Biographic Data
| ID | 7016738 |
|---|---|
| NAME | Carolin Kurz |
| GIVEN NAMES | Carolin |
| FAMILY NAME | Kurz |
| SIGNATURE | KURZ C |
| AFFILIATIONS | Ludwig-Maximilians-Universität München |
| ORCID | 0000-0003-4299-6240 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Development of a short version of the German subjective cognitive decline questionnaire (SCD-Q17)
Since it was shown that Alzheimer’s disease (AD) begins many years before the onset of symptoms with subjective cognitive decline (SCD), there has been increasing interest in the early clinical stages where disease-modifying drugs are expected to have the greatest benefit. However, at this early stage cognitive testing may yield unremarkable results, it is necessary to find a tool that can provide a simple and reliable indication of SCD as a part…
Biobanking in everyday clinical practice in psychiatry—The Munich Mental Health Biobank
Translational research on complex, multifactorial mental health disorders, such as bipolar disorder, major depressive disorder, schizophrenia, and substance use disorders requires databases with large-scale, harmonized, and integrated real-world and research data. The Munich Mental Health Biobank (MMHB) is a mental health-specific biobank that was established in 2019 to collect, store, connect, and supply such high-quality phenotypic data and bio…
No prominent works on this page.
Biobanking in everyday clinical practice in psychiatry—The Munich Mental Health Biobank
Translational research on complex, multifactorial mental health disorders, such as bipolar disorder, major depressive disorder, schizophrenia, and substance use disorders requires databases with large-scale, harmonized, and integrated real-world and research data. The Munich Mental Health Biobank (MMHB) is a mental health-specific biobank that was established in 2019 to collect, store, connect, and supply such high-quality phenotypic data and bio…
Development of a short version of the German subjective cognitive decline questionnaire (SCD-Q17)
Since it was shown that Alzheimer’s disease (AD) begins many years before the onset of symptoms with subjective cognitive decline (SCD), there has been increasing interest in the early clinical stages where disease-modifying drugs are expected to have the greatest benefit. However, at this early stage cognitive testing may yield unremarkable results, it is necessary to find a tool that can provide a simple and reliable indication of SCD as a part…
Clinical Psychology (2 works) · Psychiatry (2 works) · Psychology (2 works) · Biobank (1 work) · Bioinformatics (1 work) · Bipolar disorder (1 work) · Clinical Psychology (1 work) · Cognition (1 work) · Cognitive Abilities and Testing (1 work) · Dementia and Cognitive Impairment Research (1 work)